DeepMed Research

National Heart, Lung, and Blood Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Natural Killer Cells and Bortezomib to Treat Cancer

Phase 1

Completed

Conditions: Colon/Rectal Ca
Chronic Myeloid Leukemia (CML)
Pancreatic Ca
Multiple Myeloma
Carcinoma, Non-Small -Cell Lung

Interventions: Biological: NK cells
Drug: Bortezomib

First Posted Date: 2008-07-23

Last Posted Date: 2025-05-06

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 35

Registration Number: NCT00720785

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers

Terminated

Conditions: Healthy

First Posted Date: 2008-07-22

Last Posted Date: 2019-12-16

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 107

Registration Number: NCT00720460

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Screening for Subjects to Participate in Studies of Blood Disorders

Completed

Conditions: G-CSF
Sickle Cell Disease
Bone Marrow Transplant

First Posted Date: 2008-06-11

Last Posted Date: 2021-04-08

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 816

Registration Number: NCT00695123

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Long-term Oxygen Treatment Trial

Phase 3

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Supplemental oxygen therapy

First Posted Date: 2008-06-06

Last Posted Date: 2017-05-10

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 738

Registration Number: NCT00692198

Locations: 🇺🇸
Pulmonary Consultants Inc./Christian Hospital, St. Louis, Missouri, United States
🇺🇸
Temple University, Philadelphia, Pennsylvania, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

and more 36 locations

The Women's Health Initiative Memory Study (The WHIMS Study)

Completed

Conditions: Dementia Syndromes

Interventions: Drug: Estrogen plus progesterone hormone therapy
Drug: Placebo
Drug: Estrogen hormone therapy

First Posted Date: 2008-05-28

Last Posted Date: 2015-10-19

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 7525

Registration Number: NCT00685009

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

Phase 2

Completed

Conditions: Diabetes Mellitus
Obesity
Hypertension
Dyslipidemia
Atherosclerosis

First Posted Date: 2008-04-24

Last Posted Date: 2019-12-17

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 270

Registration Number: NCT00666172

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Biomarkers in Exhaled Breath From Asthmatic Patients

Terminated

Conditions: Asthma

First Posted Date: 2008-03-13

Last Posted Date: 2019-12-05

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 19

Registration Number: NCT00635271

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluation of Toxicity From Stem Cell Transplant

Completed

Conditions: Organ Dysfunction
Hemolysis

First Posted Date: 2008-03-10

Last Posted Date: 2019-06-17

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 61

Registration Number: NCT00631787

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk

Completed

Conditions: Cardiovascular Diseases
Atherosclerosis

First Posted Date: 2008-02-12

Last Posted Date: 2016-07-29

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 120

Registration Number: NCT00613158

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Association Between Abdominal Body Composition, Inflammation, and Risk for Cardiovascular Disease (The MESA ABD Study)

Completed

Conditions: Cardiovascular Diseases
Obesity

First Posted Date: 2008-02-11

Last Posted Date: 2016-07-29

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 1975

Registration Number: NCT00612365

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy